ArticleFrontiers in neurology2026
Patent foramen ovale is associated with white matter hyperintensities in young adults: a case-control study.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the association between patent foramen ovale (PFO) and white matter hyperintensities (WMH) in young adults and to assess whether PFO may be associated with WMH in this population. Methods: A multicenter retrospective case-control study was conducted. 120 young adult PFO patients aged 18-55 years diagnosed between October 2025 and March 2026 at two tertiary general hospitals in Chongqing, China, formed the case group. 121 age- and sex-matched controls were selected from the same period. The control group consisted of individuals who underwent cranial MRI and PFO-related examinations during the same period for similar clinical indications (e.g., headache, dizziness, or cryptogenic stroke/TIA workup) but were confirmed to have no PFO by transesophageal echocardiography. These participants were not necessarily "healthy" in the community sense but served as a clinical control group without the exposure of interest (PFO). Clinical data were collected for both groups. Transesophageal echocardiography (TEE) and cranial magnetic resonance imaging (MRI) were performed to measure PFO diameter and assess right-to-left shunt (RLS) severity. WMH severity was graded using the Fazekas scale. The chi-square test and Mann-Whitney Results: WMH grade was significantly higher in the PFO group than in the control group ( Conclusion: These findings suggest that PFO diameter may be associated with WMH severity in young adults. The underlying mechanisms remain to be elucidated and warrant further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.